Matches in Nanopublications for { ?s ?p "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215854.RAmn5Z_0EpuQDUdL1PCeUM50iLALnMDJ2a9AAS5dy34iM130_provenance.
- NP1215855.RAihHIn0iT63NgpGW5mJxnNcxWX_WJy-DWhNquClBCX-8130_assertion description "[The renin-angiotensin-aldosterone system blockade is central to the current treatment of patients with chronic kidney disease (CKD) for the renoprotective effects aimed to prevent or slow progression to end-stage renal disease (ESRD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215855.RAihHIn0iT63NgpGW5mJxnNcxWX_WJy-DWhNquClBCX-8130_provenance.